Xiaomi, BYD, and others have launched "blood replenishment" plans, with the scale of refinancing in the Hong Kong stock market exceeding HKD 100 billion this year

On the morning of March 25th, Xiaomi Corporation announced that it would allocate 800 million shares through a "first old, then new" method, raising approximately HKD 42.5 billion. Previously, on March 4th, BYD COMPANY announced the completion of an H-share placement plan amounting to HKD 43.5 billion. According to industry insiders cited by the Shanghai Securities Journal, the Hong Kong stock market is a "fertile ground" for high-quality enterprises to refinance. Since the beginning of this year, the scale of refinancing in the Hong Kong stock market has exceeded HKD 110 billion, far surpassing the amount raised through IPOs. High-tech enterprises have high R&D investments and accelerated global layouts, making refinancing an important channel for companies to "replenish blood."